Search

Your search keyword '"Kaminski, James"' showing total 232 results

Search Constraints

Start Over You searched for: Author "Kaminski, James" Remove constraint Author: "Kaminski, James"
232 results on '"Kaminski, James"'

Search Results

1. B-cell–directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primates

2. CXCR3 regulates stem and proliferative CD8+ T cells during chronic infection by promoting interactions with DCs in splenic bridging channels

3. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity

4. T cell self-reactivity during thymic development dictates the timing of positive selection.

5. A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL).

6. Reshaping of Local Alloimmunity By Organ-Specific Microenvironments during Acute Gvhd.

8. The epigenetic landscape of T cell exhaustion

9. B cell directed CAR-T cell therapy results in activation of CD8+ cytotoxic CAR-negative bystander T cells in both non-human primates and patients

10. Single-Cell RNA-Seq Reveals an Interferon-Driven Inflammatory CD4 Naïve T Cell Subpopulation at Day 100 in Hematopoietic Stem Cell Transplant Patients That Ultimately Develop Chronic Gvhd

11. CAR-T Cell Infusion Results in Activation of CD160+/NKG2D+/CCL5+ Non-CAR CD8+ Cytotoxic 'Bystander' T Cells in Both Non-Human Primates (NHP) and Patients Receiving B-Cell-Directed CAR-Ts

12. Single-Cell RNA-Seq Reveals an Interferon-Driven Inflammatory CD4 Naïve T Cell Subpopulation at Day 100 in Hematopoietic Stem Cell Transplant Patients That Ultimately Develop Chronic Gvhd

13. Targeting CNS Lymphoma with Intravenous Axicabtagene Ciloleucel: Evidence for Transcriptional Evolution Towards a Prominent Interferon Signature in CAR-T Cells Trafficking to the Tumor Site

15. The Regulation of CD8+ T Cell Fate by Transcription Factor Binding and Chromatin Accessibility

16. Identification and Tracking of Alloreactive T Cell Clones in Rhesus Macaques Through the RM-scTCR-Seq Platform

18. Longer Term Follow-up of a Multicenter, Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, Rituximab (iFCR) As Initial Therapy for Younger Patients with Chronic Lymphocytic Leukemia

20. Enhanced T Cell Function of PTPN2 Deleted CAR-T Cells Comes at a Cost: PTPN2 Knockout CAR-Ts Secrete More Cytokines and Demonstrate Increased Cytotoxicity, but Exhibit More Severe CRS and Icans in a Non-Human Primate Model

23. Predicting Immune Pathology after Hematopoietic Stem Cell Transplant (HCT) with Day 100 Transcriptomics: Naïve CD4 T Cell Expansion Versus Regulatory Programming Predicts Patients Who Develop De Novo Chronic Gvhd (CGVHD) Versus Those Displaying Operational Immune Tolerance

24. The active site of a zinc-dependent metalloproteinase influences the computed pK(sub a) of ligands coordinated to the catalytic zinc ion

27. Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8 + T cells drive gastrointestinal acute graft-versus-host disease

28. Batf-mediated Epigenetic Control of Effector CD8+ T Cell Differentiation

29. Predicting Immune Pathology after Hematopoietic Stem Cell Transplant with Transcriptomics: Naïve CD4 T Cell Expansion at Day 100 Predicts Patients with De Novo Chronic Gvhd

30. Spatiotemporal single-cell profiling of gastrointestinal GVHD reveals invasive and resident memory T cell states

32. CONTRIBUTORS

33. Batf-mediated epigenetic control of effector CD8+ T cell differentiation.

36. 10 - Predicting Immune Pathology after Hematopoietic Stem Cell Transplant (HCT) with Day 100 Transcriptomics: Naïve CD4 T Cell Expansion Versus Regulatory Programming Predicts Patients Who Develop De Novo Chronic Gvhd (CGVHD) Versus Those Displaying Operational Immune Tolerance

37. Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.

38. Milwaukee's ozone upgrade

41. B-cell–directed CAR T-cell therapy activates CD8+cytotoxic CARnegbystander T cells in patients and nonhuman primates

46. Metabolic stabilization of benzylidene ketal M2 muscarinic receptor antagonists via halonaphthoic acid substitution

50. ChemInform Abstract: Dual Antagonists of Platelet Activating Factor and Histamine. Part 3. Synthesis, Biological Activity and Conformational Implications of Substituted N‐Acyl‐bis‐arylcycloheptapiperazines.

Catalog

Books, media, physical & digital resources